NovaBridge Biosciences American Depositary Shares
NBP
65 hedge funds and large institutions have $616M invested in NovaBridge Biosciences American Depositary Shares in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 5 reducing their positions, and 6 closing their positions.
340% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 5
300% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 6
38% more capital invested
Capital invested by funds: $448M → $616M (+$168M)
35% more funds holding
Funds holding: 48 → 65 (+17)
4.53% more ownership
Funds ownership: 12.21% → 16.73% (+4.5%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cederberg Capital
London,
United Kingdom
|
+$70M |
| 2 |
WA
WFM Asia
Road Town, Tortola,
British Virgin Islands
|
+$29.6M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$9.88M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$8.83M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$8.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$7.61M |
| 2 |
YRHAM
Yong Rong (HK) Asset Management
Sheung Wan,
Hong Kong
|
-$1.88M |
| 3 |
CCM
CAAS Capital Management
New York
|
-$1.65M |
| 4 |
Goldman Sachs
New York
|
-$1.61M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.06M |
NBP Hedge Fund Activity: Q4 2020 in Review
65 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q4 2020, worth a combined $616M — up 38% from $448M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new NBP positions and 6 closed out — a net gain of 18 holders — while 22 added to existing stakes and 5 trimmed.
The largest buyer was Cederberg Capital, opening a new position worth an estimated $70M. The largest seller was Manulife (Manufacturers Life Insurance), cutting an estimated $7.61M.
- 65 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q4 2020, up from 48 in Q3 2020.
- Funds reported $616M of NovaBridge Biosciences American Depositary Shares stock for Q4 2020, up 38% quarter-over-quarter.
- 24 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q4 2020 and 6 closed out, a net change of +18 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q4 2020 was Cederberg Capital, an estimated $70M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q4 2020 was Manulife (Manufacturers Life Insurance), an estimated $7.61M sold.
Based on aggregated 13F filings for Q4 2020.